During the past decade, Middle East Institute of Health- Bsaleem conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Middle East Institute of Health- Bsaleem" are "Colorectal Cancer" (1 trials), "Gastrointestinal Stromal Tumors" (1 trials), "Non-Squamous Non-Small Cell Lung Cancer" (1 trials) and "Pancreatic Cancer" (1 trials). Many other conditions were trialed in "Middle East Institute of Health- Bsaleem" in a lesser frequency.

Most popular intervention types in "Middle East Institute of Health- Bsaleem" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Masitinib" (2 trials), "Bevacizumab" (1 trials), "Docetaxel" (1 trials), "Erlotinib" (1 trials) and "Gemcitabine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Middle East Institute of Health- Bsaleem" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Middle East Institute of Health- Bsaleem". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Middle East Institute of Health- Bsaleem, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Middle East Institute of Health- Bsaleem, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".